Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/05/2006 | CA2179183C Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
12/05/2006 | CA2159058C Inhibition of helicobacter |
12/05/2006 | CA2130787C Ursodeoxycholic acid-containing medicament in a liquid administration form |
11/30/2006 | WO2006128110A2 Intermittent flow extrusion process and food product |
11/30/2006 | WO2006127899A2 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
11/30/2006 | WO2006127898A2 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
11/30/2006 | WO2006126675A1 Agent for external application to the skin |
11/30/2006 | WO2006126637A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
11/30/2006 | WO2006126529A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
11/30/2006 | WO2006126514A1 Arylacetate derivative having isoxazole skeleton |
11/30/2006 | WO2006125293A1 Derivatives of 4- or 5-aminosalicylic acid |
11/30/2006 | WO2006037748A8 Substituted tricyclic benzimidazoles |
11/30/2006 | US20060270738 Novel derivatives of 3,3-diphenylpropylamines |
11/30/2006 | US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents |
11/30/2006 | US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha |
11/30/2006 | US20060270693 Ether derivative |
11/30/2006 | US20060270681 Pyridazine derivatives |
11/30/2006 | US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
11/30/2006 | US20060270676 Hydrazono-malonitriles |
11/30/2006 | US20060270674 Pharmaceutical composition promoting defecation |
11/30/2006 | US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
11/30/2006 | US20060270649 Azetidine derivatives, their preparation and medicaments containing them |
11/30/2006 | US20060269953 Novel hepatitis B virus |
11/30/2006 | US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia |
11/30/2006 | US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis |
11/30/2006 | US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
11/30/2006 | US20060269510 Orlistat compositions |
11/30/2006 | CA2609904A1 Intermittent flow extrusion process and food product |
11/30/2006 | CA2609662A1 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
11/30/2006 | CA2609393A1 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
11/30/2006 | CA2607280A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
11/29/2006 | EP1726638A1 Novel lactic acid bacterium |
11/29/2006 | EP1726585A1 Diaryl-substituted five-membered heterocycle derivative |
11/29/2006 | EP1726311A2 Migration of hematopoietic stem cells and progenitor cells to the liver |
11/29/2006 | EP1726305A1 Zinc salt of omeprazole and its enantiomers |
11/29/2006 | EP1725230A1 Methimazole derivatives and tautomeric cyclic thiones to inhibit cell adhesion |
11/29/2006 | EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
11/29/2006 | EP1725223A2 Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic deseases |
11/29/2006 | EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides |
11/29/2006 | EP1478381A4 Use of soluble gamma delta t cell receptors for regulating t cell function |
11/29/2006 | EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
11/29/2006 | EP1023049B1 Preparation of a directly mouldable tabletting auxiliary |
11/29/2006 | EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents |
11/29/2006 | CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
11/29/2006 | CN1871024A Remedy and therapeutic method for periodontal diseases and pulpal diseases |
11/29/2006 | CN1871002A Alkynes II |
11/29/2006 | CN1871001A Alkynes III |
11/29/2006 | CN1870999A Alkynes I |
11/29/2006 | CN1869238A Biological agent for repairing ulcer |
11/29/2006 | CN1869237A Construction method of bismall molecule interference RNA carrier and its application |
11/29/2006 | CN1869220A Application of ShRNA pointed at HBV gene in inhibiting hepatitis B virus duplication |
11/29/2006 | CN1869208A Preparation of caterpillar fungus SOD and health-care product containing caterpillar fungus SOD |
11/29/2006 | CN1869061A Peptidomimetic protease inhibitors |
11/29/2006 | CN1869031A Lactone monomer compound and its application in preparing anticancer medicine |
11/29/2006 | CN1868531A Traditional Chinese medicine composition for treating hepatolith |
11/29/2006 | CN1868524A Shengmai dripping pills and its preparing method |
11/29/2006 | CN1868520A Compound Barbados aloe soft-capsule prepn. and its preparing method |
11/29/2006 | CN1868519A Formula for Liuwei Dihuang with vitamin prepns., prepn. method and application therefor |
11/29/2006 | CN1868518A Shen-nao capsule for treating nephrosis and cardiovascular and cerebrovascular disease and its prepn. method |
11/29/2006 | CN1868504A Method for preparing Weigan Futai capsule for treating liver complaint |
11/29/2006 | CN1868501A Compound isatic root oral liquor prepn. and its prepn. method |
11/29/2006 | CN1868500A Medicine composition contg. tetramethylpyrazine, prepn. method and use thereof |
11/29/2006 | CN1868491A Medicine for radical cure of rheumatic arthritis and rheumatoid arthritis |
11/29/2006 | CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
11/29/2006 | CN1868486A Medicine composition used for cleaning intestinal tract |
11/29/2006 | CN1868481A Traditional Chinese medicine cucurbitacine soft capsule and its prepn. method |
11/29/2006 | CN1868475A Nasal cavity nebula contg. scopolamine hydrobromide |
11/29/2006 | CN1868473A Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method |
11/29/2006 | CN1868465A Application of anthraquinone derivatives (emodin) for pharmacy |
11/29/2006 | CN1868463A Slow-release prepn. contg. alpha-lipoic acid or its derivatives, and preparing method therefor |
11/29/2006 | CN1868461A Tegaserod maleate oral prepn. |
11/29/2006 | CN1868457A Prepn. method of matrine magnetic micro-ball |
11/29/2006 | CN1868456A Prepn. of antisense deoxyoligonucleotide ISIS23665 elaioplast, and its prepn. method |
11/29/2006 | CN1868331A Beverage for enteric health-care |
11/29/2006 | CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
11/29/2006 | CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/29/2006 | CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound |
11/29/2006 | CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy |
11/29/2006 | CN1286522C Medicine for treating gastric and duodenal ulcer |
11/29/2006 | CN1286521C Medication for treating ulcer disease, gastritis, stomachache, abdominal pain |
11/29/2006 | CN1286519C Medicinal composition for treating cholelithiasis and its preparing method |
11/29/2006 | CN1286518C Chinese medicinal prescription for treating gastropathy |
11/29/2006 | CN1286514C Compound rose essential oil soft capsule and its preparation method |
11/29/2006 | CN1286509C Life-cultivation liquor, and its preparing method |
11/29/2006 | CN1286507C Combination of Chinese traditional medicine of having effect of prolonging life and adjusting incretion |
11/29/2006 | CN1286506C Nutrient oral liquid |
11/29/2006 | CN1286501C Medicine composition for treating stomach disease, its preparation method and use |
11/29/2006 | CN1286499C Chinese traditional medicine for treating diarrhea of infant and preparation method |
11/29/2006 | CN1286488C Method for extracting general alkaloid of Chinese goldthread and evodia fruit |
11/29/2006 | CN1286485C Medicine for stopping pain of stomach intestine and preparation process thereof |
11/29/2006 | CN1286483C Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins |
11/29/2006 | CN1286475C Chinese medicine for treating liver disease |
11/29/2006 | CN1286473C Chinese medicinal preparation with viral infection resisting function |
11/29/2006 | CN1286469C Pharmaceutical use of isolarisiresinol |
11/29/2006 | CN1286468C Alinate/alginic acid composition |
11/29/2006 | CN1286464C Pharmaceutical composition for protecting liver, preventing and treating liver cancer |
11/29/2006 | CN1286457C Freeze-dried powder injection of andrographolide and preparation thereof |
11/29/2006 | CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural |
11/28/2006 | US7141662 Diagnosis using antibodies; culture product |
11/28/2006 | US7141597 1 ((+)-(S)-4-[1-(2,3-dimethyl-phenyl)-ethyl]-1-1,3-dihydro-imidazole-2-thione) for treatment of chronical pain, diabetes, hyperglycemia, hypertriglyeridemia, decreased levels of blood insulin and hyperlipidemia |